Spojené štáty - angličtina - NLM (National Library of Medicine)

dse healthcare solutions, llc - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - menthol 2.5 g in 100 g

Spojené štáty - angličtina - NLM (National Library of Medicine)

clarion brands, llc - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - menthol 2.5 g in 100 g - topical analgesic for temporary relief of minor aches and pains of muscles and joints associated with: - arthritis - simple backache - sprains - strains - bruises

Spojené štáty - angličtina - NLM (National Library of Medicine)

silver star brands - cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), matricaria recutita (unii: g0r4ubi2zz) (matricaria recutita - unii:g0r4ubi2zz), coffea arabica fruit (unii: hox6bek27q) (coffea arabica fruit - unii:hox6bek27q), artemisia cina flower (unii: 28m1820act) (artemisia cina flower - unii:28m1820act) - cinchona officinalis bark 30 [hp_c] in 59 ml - homeopathic remedy to relieve occasional sleeplessness and restlessness in toddlers and children. *this statement has not been evaluated by the food and drug administration. this product is not intended to diagnose, treat, cure or prevent any disease. relieves occasional sleeplessness & restlessness in toddlers & children

Spojené štáty - angličtina - NLM (National Library of Medicine)

clarion brands, llc - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - menthol 6500 mg in 1 h - topical analgesic for temporary relief of minor aches and pains of muscles and joints associated with: - simple backache - arthritis - sprains - strains - bruises

Spojené štáty - angličtina - NLM (National Library of Medicine)

clarion brands, llc - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - menthol 5000 mg in 1 h - for temporary relief of minor aches and pains of muscles and joints associated with: - simple backache - arthritis - sprains - strains - bruises

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - ustekinumab, quantity: 45 mg - injection, solution - excipient ingredients: histidine; polysorbate 80; histidine hydrochloride monohydrate; water for injections; sucrose - plaque psoriasis,adults - stelara is indicated for the treatment of adult patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.,paediatric population, 6 years and older - stelara is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescent patients from 6 years of age who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.,psoriatic arthritis (psa),stelara, alone or in combination with methotrexate, is indicated for the treatment of signs and symptoms of active psoriatic arthritis in adult patients (18 years and older) where response to previous non-biological dmard therapy has been inadequate.,crohn?s disease,stelara is indicated for the treatment of adult patients with moderately to severely active crohn?s disease who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a tnf alpha antagonist or have medical contraindications to such therapies.,ulcerative colitis,stelara is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - adrenaline (epinephrine), quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. epipen and epipen jr. are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. epipen and epipen jr. are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylax

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - adrenaline (epinephrine), quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. adrenaline mylan and adrenaline jr mylan are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens.

Spojené štáty - angličtina - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardial infarc

Spojené štáty - angličtina - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardial infarc